Nearly half of people diagnosed with an anxiety disorder also meet the criteria for a substance use disorder, according to SAMHSA’s 2022 National Survey on Drug Use and Health. That overlap is not coincidence. The anxiety and substance abuse connection runs through biology, behavior, and brain chemistry in ways that make each condition actively reinforce the other, and understanding that loop is the first step toward breaking it.
How anxiety and substance abuse feed each other
SAMHSA’s 2022 data found that roughly 9.2 million adults in the United States live with co-occurring mental health and substance use disorders. Of those, anxiety disorders represent the most common mental health pairing with addiction. The mechanism is straightforward once you see it: anxiety creates unbearable internal pressure, substances reduce that pressure fast, and the brain learns the connection. Each time that sequence repeats, the bond between distress and substance use gets stronger.
The catch is that the relief never lasts. What the substance suppresses in the short term rebounds harder later, leaving baseline anxiety elevated. That elevated anxiety then drives more use. This is not a character flaw or a lack of willpower. It is a self-reinforcing loop that the brain builds and then defends. If you are dealing with both anxiety and substance use, treating only one side of that equation is the most common reason past attempts did not hold.
If you are currently in crisis or having thoughts of self-harm, stop reading and call or text 988 right now, or go to the nearest emergency room.
Why the brain reaches for substances when anxiety hits
A 2021 study published in Neuropsychopharmacology, examining stress-response pathways in over 1,000 participants, found that alcohol and sedative substances directly suppress cortisol output in the short term, producing a measurable reduction in perceived stress within 20 to 30 minutes of use. That is the biology behind why a drink feels calming after a hard day.
The dopamine layer makes it stickier. When a substance delivers relief from anxiety, the brain releases dopamine as a reward signal, flagging the behavior as something worth repeating. Over time, the brain begins to anticipate that relief and generates craving before anxiety even spikes, meaning the trigger for use starts moving earlier in the cycle. Understanding this reflex matters practically: once you recognize that the urge to use is often a stress-response signal firing too early, you have a point to intervene, rather than feeling blindsided by the craving.
The most common substances people use to manage anxiety
A 2020 NIH National Institute on Alcohol Abuse and Alcoholism epidemiological analysis of over 36,000 adults found that alcohol, cannabis, opioids, and benzodiazepines account for the majority of substances used in the context of self-managing anxiety symptoms. Each works differently, and each fails differently.
Alcohol
A 2019 study in the Journal of Anxiety Disorders tracking 3,700 adults over four years documented what researchers call the “anxiogenic rebound” effect: after alcohol clears the system, GABA activity drops below its pre-drinking baseline, producing a spike in anxiety that often exceeds what the person felt before drinking. The short-term calm is real. The longer-term cost is a higher anxiety floor that pushes the next drink to feel necessary sooner.
Cannabis
Research published in Psychological Medicine in 2022, drawing on data from over 45,000 participants, found that high-THC cannabis products increase the risk of anxiety disorder onset by 27% over a five-year period among regular users. Short-term relief is genuine for many people, especially at lower doses. But as tolerance builds and use increases, the baseline anxiety level shifts upward, and stopping use then triggers its own anxiety surge. For a meaningful share of people researching this overlap, cannabis is the substance they least expect to be contributing to the problem.
Opioids and benzodiazepines
A 2020 study in JAMA Psychiatry, following 12,000 patients prescribed benzodiazepines for anxiety, found that 40% developed physical dependence within eight weeks of daily use. That physical dependence creates a second layer of complexity: withdrawal from benzodiazepines produces anxiety symptoms that can exceed the original disorder in intensity. Opioids follow a similar path. Both suppress the stress-response system powerfully, but both produce withdrawal-driven anxiety that feels indistinguishable from the underlying condition, making it extremely difficult to assess what is happening clinically without integrated care.
Which comes first: anxiety or substance use?
This question comes up constantly, and the honest answer is that both sequences happen. A 2017 Harvard longitudinal cohort study tracking 1,300 adults over 20 years found that in 60% of co-occurring cases, the anxiety disorder appeared first, with substance use beginning as a coping strategy. In the remaining 40%, chronic substance use either triggered or significantly worsened anxiety through neurological changes over time.
What this means in practice: the order of onset shapes the treatment approach, but it does not change the core conclusion. Both conditions are present, both are active, and both require direct attention in treatment. Focusing only on the addiction while leaving anxiety unaddressed leaves the primary driver of use intact. Focusing only on anxiety while ignoring the substance use leaves a pharmacological override in place that blocks therapeutic progress.
Why this combination is harder to treat without dual diagnosis care
SAMHSA’s National Survey on Drug Use and Health found that adults receiving integrated treatment for co-occurring disorders, meaning treatment that addresses both conditions simultaneously within the same program, show significantly better outcomes than those receiving sequential care, where one condition is treated first and the other addressed later, if at all.
The reason comes down to interaction. Anxiety and substance use do not sit side by side as separate problems. They share neural pathways, behavioral patterns, and emotional triggers. When a program treats addiction in isolation, anxiety continues to generate the pressure that drives use. When a program treats anxiety in isolation, the substance use continues to destabilize mood and interfere with therapeutic progress. What qualifies as true co-occurring care is worth understanding before choosing a program, because the label “dual diagnosis” is applied loosely in the field, and not all programs that use it deliver integrated treatment in practice.
A program built for this work treats both conditions from the first session, with the same clinical team, inside the same treatment plan.
How anxiety and substance abuse show up differently by population
A 2021 study in Psychiatric Services, analyzing data from over 20,000 adults across socioeconomic groups, found that lower-income adults with co-occurring disorders are significantly less likely to receive integrated care, largely due to stigma, access barriers, and programs that screen for substance use but not mental health, or vice versa.
This pattern shows up clearly in Riverside County and the broader Inland Empire. For a working adult managing a household and a job simultaneously, the barrier to treatment is not just motivation, it is logistics. For someone completing probation or parole, the pressure to demonstrate sobriety can actually suppress disclosure of anxiety symptoms out of fear of judgment. For Spanish-speaking individuals, the availability of culturally and linguistically appropriate care narrows the options significantly. Knowing your specific barrier, whether it is scheduling, language, stigma, or court-related pressure, helps you find the entry point that fits your situation rather than the one that fits the average case.
What effective treatment for both conditions actually looks like
A 2019 study in JAMA Psychiatry, a randomized controlled trial involving 1,100 adults with co-occurring anxiety and substance use disorders, found that integrated treatment combining cognitive behavioral therapy with appropriate medication management produced a 34% greater reduction in both anxiety severity and substance use frequency compared to sequential single-diagnosis treatment.
The structure of effective integrated care has three primary components, and all three work together rather than in isolation.
Cognitive behavioral therapy (CBT) for co-occurring disorders
CBT targets the thought-behavior loop that drives both anxiety and substance use at the same time. A 2020 meta-analysis in Clinical Psychology Review, covering 48 trials and over 3,000 participants, confirmed CBT as the most evidence-supported psychotherapy for co-occurring anxiety and addiction. In practice, CBT sessions identify the specific thought patterns that generate anxiety, then map where substance use enters as a response, and build concrete alternative responses at each point in the chain. You leave sessions with skills you can apply the same day, not just insight about the past.
Medication-assisted treatment and anxiety management
FDA-approved medications play a distinct role in integrated treatment. Naltrexone reduces the reward signal associated with alcohol and opioid use, making the dopamine payoff from substance use smaller and less reinforcing. SSRIs and SNRIs address the underlying anxiety disorder directly, reducing the baseline pressure that drives self-medication. A 2021 study in Addiction Biology, tracking 800 adults in integrated outpatient programs, found that participants receiving both behavioral therapy and appropriately managed medication showed 41% lower relapse rates at the 12-month mark. Medication is a clinical tool that removes obstacles to therapeutic work, not a replacement for it.
For anyone navigating outpatient or IOP treatment options in Riverside County, the key question to ask any program is whether anxiety is addressed within the same treatment plan as the substance use, or referred out separately. That answer tells you a great deal about whether the care is actually integrated.
How to tell if you or someone you know needs help now
The GAD-7, a validated screening tool studied across more than 50 clinical trials and widely used by the World Health Organization, identifies generalized anxiety severity in seven questions and takes under three minutes to complete. The AUDIT-C, validated across populations in a 1998 study published in the Archives of Internal Medicine and replicated dozens of times since, screens for alcohol use disorder with three questions. Both are available free online.
The behavioral signs that anxiety and substance use have crossed into co-occurring territory include using substances specifically to manage anxiety or sleep, finding that anxiety spikes noticeably when you are unable to use, experiencing anxiety that is worse the day after use than it was before, and noticing that previous treatment for either condition did not produce lasting change. These are not character failings. They are data points that tell you the problem has two parts.
The concrete first step is a call to a treatment provider who offers co-occurring assessments, not a general admissions line that screens for substance use only. That single distinction filters for the level of care that actually matches what is happening.
What to try this week
Take the GAD-7 screener online this week and write down your score. Then call a program that explicitly offers dual diagnosis assessment and share that number when you call. You do not need to have everything figured out before making that call. The assessment exists to do the figuring out for you. The smallest move that opens the door is not a commitment to a full program. It is one honest conversation with someone trained to hold both sides of this at once.
If you are in crisis or having thoughts of self-harm at any point, call or text 988 immediately, or go to the nearest emergency room.
Frequently asked questions
Can anxiety disorder develop as a result of substance use, or does it always come first?
Both directions happen. Chronic use of alcohol, stimulants, and certain other substances produces lasting changes in how the brain regulates stress hormones and neurotransmitters. These changes can create anxiety disorders in people who had no significant anxiety before heavy use began. The direction matters for treatment planning, but treatment addresses both conditions regardless of which appeared first.
Is it safe to stop using substances on your own if anxiety is also present?
Stopping alcohol or benzodiazepines without medical supervision carries real physical risk, including withdrawal seizures. Anxiety also intensifies sharply during withdrawal from most substances, which makes the process harder to manage alone and raises relapse risk. A medically supervised detox, followed by integrated treatment for both conditions, is the appropriate path.
Does treating anxiety make substance use easier to stop?
Yes, but only when treatment addresses both at the same time. Reducing anxiety through therapy and, where appropriate, medication removes a primary driver of use. On its own, however, anxiety treatment does not address the physical dependence, behavioral patterns, or dopamine-related reinforcement that sustain substance use. Integrated care handles all of those simultaneously.
What does “dual diagnosis” actually mean in a treatment context?
Dual diagnosis refers to the presence of a mental health condition and a substance use disorder occurring together in the same person. In a treatment context, it describes a program designed to assess and address both within a single coordinated plan. Not all programs that advertise dual diagnosis deliver true integration, so asking how mental health concerns are incorporated into the treatment plan, rather than referred out, is the right question.
How do I know if a treatment program is equipped to handle both anxiety and addiction?
Ask the program directly whether anxiety is treated within the same clinical team and treatment plan as the substance use, or whether mental health concerns are referred to a separate provider. Ask whether the program uses validated screening tools for both conditions at intake. A program built for co-occurring care answers both questions clearly and without hesitation.
Can someone on medi-cal access integrated co-occurring treatment in riverside county?
Yes. Medi-Cal covers outpatient and intensive outpatient programming for co-occurring disorders through the Drug Medi-Cal Organized Delivery System in California. Riverside County has certified providers who accept Medi-Cal for this level of care. Asking a prospective program directly about Medi-Cal acceptance and co-occurring services at the same time confirms whether both needs are covered under a single plan.
